Although prescription pain killers are generally safe, long-term use can be dangerous. Repeated use of opioids causes brain receptors to become insensitive, which means that higher doses are needed to achieve the same effect. Ultimately, this can lead to an addiction. Opioids are also addictive, resulting in long-term brain damage. Moreover, they depress breathing, making the user dependent on artificial endorphins and less likely to produce the body’s own. Although these pain-relieving drugs can be dangerous, they are extremely effective at controlling pain. They slow heart rate and breathing, and they can cause an overdose
The global opioid use disorder market is estimated to be valued at US$ 2,739.2 million in 2021 and is expected to exhibit a CAGR of 8.7% over the forecast period (2021-2028).
Receive a Free Sample of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/4597
Growing usage of buprenorphine patches as an effective treatment option for opioid use disorder is driving the market growth
Increasing usage of buprenorphine patches as an effective therapy for opioid use disorder is driving growth of the opioid use disorder market growth. Buprenorphine patches are novel approach for the treatment of opioid use disorder. The utilization of transdermal patches has various advantages over other treatment modes such as injections as it is the most easy and comfortable mode of drug delivery, which effectively reduces the pain and can be self-administered by the patient.
For instance, in April 2020, WellSpan Health, a U.S.-based healthcare company, collaborated with York Opioid Collaborative, a public health and safety organizations, to establish a clinical trial and reached phase IV in the development of Lidocaine patch for the indication of opioid use disorder. This is expected to boost the adoption of treatment on a broader scale.
Growing cases of opioid addiction is expected to drive the market growth over the forecast period
Increasing number of patient population suffer from a wide range of severe and chronic diseases, such as cancer, cardiovascular disease, pain arising from injuries, and other conditions is driving market growth. These diseases mostly cause chronic pain that are managed with the consumption of painkillers, mostly opioids.
For instance, according to the World Health Organization’s report, about 0.5 million deaths are attributable to drug use globally. More than 70% of these deaths are related to opioids, with more than 30% of those deaths caused by overdose in 2020.
According to the Centre for Disease Control and Prevention report, opioids were involved in 49,860 overdose deaths in 2019 (70.6% of all drug overdose deaths) in the U.S.
Furthermore, according to the article published in the National Center for Biotechnology Information in July 2018, India has twice the global average prevalence of illicit opiate consumption. It is estimated that, India has about 4 million people who use opioids and around 1 million people who are opioid dependent in 2018.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables& Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-pdf/4597
Global Opioid Use Disorder Market – Impact of Coronavirus (Covid-19) Pandemic
The coronavirus pandemic has a varied impact on the pharmaceutical market, ranging from positive to negative, based on the demand. There has been a negative impact on certain medication, owing to a decline in their demand due to the lack of visits to the healthcare facilities such as hospitals and clinics. Furthermore, to decrease the number of coronavirus cases, several governments have implemented strict nationwide lockdown. This has led to sharp decline in the flow of patients across hospital settings. Moreover, the cancellation or postponement of non-essential medical procedures has further led to a negative impact on market growth.
However, the prominent companies engaged in the opioid use disorder market, such as Indivior PLC, experienced an overall decline in its product revenues during the pandemic. Thus, rapid decline in sales has occurred due to COVID-19 related disruption such as lockdown, lack of transportation, and others. Thus, the global opioid use disorder market is expected to experience a negative impact.
Global Opioid Use Disorder Market Restraint
Factor such as side effects that may arise from the drugs administered for the treatment of opioid addiction is hindering market growth. Some of the typical adverse reaction from these drugs are vomiting, bladder pain, abdominal cramps, diarrhea, respiratory complications, bone or joint pain, muscle aches, and constipation.
Key Players
Major players operating in the global opioid use disorder market include Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, BioDelivery Sciences International Inc., Viatris Inc., Pfizer, Inc., Hikma Pharmaceuticals PLC, and Camurus.
Buy the Full Research report With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/4597
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Pipeline Analysis
- PEST Analysis
- Epidemiology
- Regulatory Scenario
- Reimbursement Scenario
- Acquisitions and Collaboration
- Brand Analysis
- Market Dynamics
- Global Opioid Use Disorder Market – Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- Impact on Opioid Use Disorder Market
- Impact on Drug Development
- Global Opioid Use Disorder Market, By Drug Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Buprenorphine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Methadone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Naltrexone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Opioid Use Disorder Market, By Route of Administration, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Opioid Use Disorder Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/opioid-use-disorder-market-3845
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837